AC Immune SA (FRA:IMR)

AC Immune Revenue

AC Immune had revenue of 939.00K CHF in the quarter ending September 30, 2025, a decrease of -96.32%. This brings the company's revenue in the last twelve months to 4.37M, down -89.33% year-over-year. In the year 2024, AC Immune had annual revenue of 27.31M with 84.51% growth.

• Revenue (ttm): 4.37M CHF
• Revenue Growth: -89.33%
• P/S Ratio: 49.90
• Revenue / Employee: 25.42K CHF
• Employees: 172
• Market Cap: 233.20M EUR

Revenue Chart

* This company reports financials in CHF.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	27.31M	12.51M	84.51%
Dec 31, 2023	14.80M	10.87M	276.14%
Dec 31, 2022	3.94M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	15.43M	-95.03M	-86.03%
Dec 31, 2019	110.46M	103.54M	1,498.03%
Dec 31, 2018	6.91M	-13.34M	-65.88%
Dec 31, 2017	20.26M	-2.96M	-12.75%
Dec 31, 2016	23.21M	-15.88M	-40.61%
Dec 31, 2015	39.09M	8.82M	29.14%
Dec 31, 2014	30.27M	21.63M	250.46%
Dec 31, 2013	8.64M	-	-